Explorer les evidences

The highest symptomatic malaria case prevalence was in Karafine (KAR).

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

66,7 %Two-third of the HIV-2 patients were men.

Côte d'IvoireVIH/sidapublié 2020PloS oneeurope_pmcdocument de 13 observationsDOI 10.1371/journal.pone.0236642

97 %Plasmodium falciparum accounted for 97% of single Plasmodium infections in northern Côte d’Ivoire during previous studies.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

15,16 %Malaria case prevalence in the LLIN group was 15.16% (502/3311) post-intervention.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

11,7 %HBsAg positivity prevalence among first-time male blood donors in Abidjan was 11.7% in 1992–1994 and 12.5% in 2010–2012.

Côte d'Ivoirehépatite Bobservé 1992–1994publié 2018Open forum infectious diseaseseurope_pmcdocument de 12 observations

2 %The AS genotype represented 2% of the samples.

Côte d'Ivoirehemoglobin disordersHAL · Unilimdocument de 23 observations

7,2 %Among the 597 patients who attended the M24 visit, the proportion who were obese increased from 7.2% to 9.2%.

Côte d'IvoireVIH/sidapublié 2016AIDS research and therapyeurope_pmcdocument de 9 observations

5,5 per_100_person-yearsIn a cohort of HIV-infected patients of sub-Saharan African origin, the incidence of metabolic syndrome was 5.5 per 100 person-years of follow-up after 3 years of combined antiretroviral therapy.

Côte d'Ivoiresyndrome métabolique · VIH/sidapublié 2015AIDS research and human retroviruseseurope_pmcdocument de 7 observations

2 %Among the 943 inmates screened at the Correctional and Detention Facility of Abidjan, 19 (2.0%) had confirmed pulmonary TB.

Côte d'Ivoirepulmonary TBobservé 2015publié 2017PloS oneeurope_pmcdocument de 8 observations

43,4 %The prevalence of malaria cases detected by RDTs was 43.4% in Survey 2.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

Among HBsAg-positive individuals, anti-HDV antibody positivity was 28.6% in HIV-1 patients, 14.3% in HIV-2 patients, and 0.0% in HIV-1&2 dually reactive patients.

Côte d'Ivoirehepatitis Delta virus · VIH/sidaobservé 2012publié 2017BMC infectious diseaseseurope_pmcdocument de 7 observations

Les cancers des femmes sont les plus incidents et meurtriers en Côte d’Ivoire.

Côte d'Ivoirecancers des femmesHAL · Unilimdocument de 81 observations

8 %The proportion of vaginal swab samples for which the PCR result was positive was 8.0% for Chlamydia trachomatis among female sex workers enrolled in the PRINCESSE cohort in Côte d'Ivoire.

Côte d'IvoireChlamydia trachomatispublié 2025Frontiers in public healtheurope_pmcdocument de 7 observationsDOI 10.3389/fpubh.2025.1535122

20,4 %Among the 597 patients who attended the M24 visit, the proportion who were overweight increased from 20.4% to 24.8%.

Côte d'IvoireVIH/sidapublié 2016AIDS research and therapyeurope_pmcdocument de 9 observations

126 cells/mm³In ART-treated patients, the CD4 count increased by 126 cells/mm³ after 24 months on ART for HIV-2 patients.

Côte d'IvoireVIH/sidaobservé 24 monthspublié 2013PloS oneeurope_pmcdocument de 14 observations

3,82 adjusted_IRRHBsAg-positive individuals with HBV-DNA ≥2000 IU/mL had an adjusted incidence rate ratio for mortality of 3.82 (95% CI = 1.11–9.70) at CD4+ counts ≤350/mm³ compared to HBsAg-negative individuals.

Côte d'Ivoirehépatite B · VIH/sidapublié 2021Antiviral therapyeurope_pmcdocument de 4 observations

68 %310 (68%) of 457 participants had bacteriologically-confirmed tuberculosis.

Côte d'Ivoiretuberculosepublié 2021The Lancet. Infectious diseaseseurope_pmcdocument de 11 observationsDOI 10.1016/s1473-3099(20)30869-0

All 95 HIV-2 patients in the cohort were receiving boosted-lopinavir-based antiretroviral treatment regimen.

Côte d'IvoireVIH/sidapublié 2025PloS oneeurope_pmcdocument de 12 observations

85,4 %Infection prevalence was 85.4% in Survey 3 among 820 participants.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

733 patientsAmong the 1,754 patients, 733 were dually seropositive for HIV-1 and HIV-2.

Côte d'IvoireVIH/sidapublié 2013PloS oneeurope_pmcdocument de 14 observations

46,8 %Plasmodium falciparum was detected in 46.8% of febrile people in Côte d'Ivoire.

Côte d'Ivoirepaludismepublié 2021Travel medicine and infectious diseasePubMeddocument de 25 observations

93,3 %The majority (93.3%) of patients was symptomatic.

Côte d'IvoireVIH/sidapublié 2010Le Mali medicaleurope_pmcdocument de 17 observations

4,7 log10_copies_per_mlAt baseline, the median plasma HIV-1 RNA was 4.7 log10 copies/ml [IQR 4.0–5.2] in HIV-infected adults in the Temprano trial.

Côte d'IvoireVIH/sidapublié 2020EBioMedicineeurope_pmcdocument de 7 observations

1 per_100_person_weeksAmong children under five years of age, malaria incidence exceeded 1 case per 100 person-weeks during the peaks in July–August and November 2016.

Côte d'Ivoirepaludismeobservé July–August 2016, November 2016HAL · Unilimdocument de 122 observations

97,15 %Plasmodium falciparum accounted for 97.15% of 2246 identified Plasmodium species.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations